SIGN IN
Email Address
Password

Practical Solutions to Critical Topics in the Management of Chronic Pain: From Bench to Bedside



To start this activity, click "Begin" at the bottom of this page.

Practical Solutions to Critical Topics in the Management of Chronic Pain: From Bench to Bedside

Release Date:

October 02, 2012

Expiration Date:

October 02, 2013

Topics:

Arthritis / Rheumatoid / Osteo
Drug Information
Fibromyalgia
Pain Management

Specialty:

Family Medicine / General Practice
Internal Medicine
Pain Medicine

Profession:

Physician

Format:

Interactive Monograph

Credits:

1.50 / AMA PRA Category 1 Credit(s)TM


Estimated Time to Complete:

1.50 hours

Program Description:

Chronic pain is a significant public health problem in the United States that is both common and costly. A significant barrier to the optimal diagnosis and treatment of chronic pain is a lack of knowledge regarding the underlying causes of chronic pain and the optimal use of analgesic compounds. This activity uses an interactive format to update clinicians on the pathophysiology of chronic pain and the mechanisms of action of common classes of analgesic therapies. The activity also features two case studies to show learners how knowledge about the pathophysiology of chronic pain and the mechanism of action of analgesic compounds can be used in daily practice.

There are five chapters in this activity. To obtain CME credit, participants must complete all chapters.

INTENDED AUDIENCE:

This activity has been designed to meet the educational needs of primary care physicians who are involved in the management of patients with chronic pain conditions.

Activity Objectives:

After completing this activity, participants should be able to:

  • Explain the pathophysiology involved in the development and maintenance of chronic pain and recognize the differences between common chronic and neuropathic pain conditions

  • Improve diagnostic accuracy when assessing patients with chronic pain

  • Formulate a treatment plan for patients with chronic pain that is based on the pathophysiology of the condition and mechanism of action of common classes of analgesic agents


Credits Type Accreditation Statement Designation Statement
1.50 AMA PRA Category 1 Credit(s)TM Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity is co-sponsored by Curatio CME Insitute, an ACCME-accredited provider. Penn State College of Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty:

Robert H. Dworkin, PhD
Professor
Department of Anesthesiology, Neurology, Oncology, and Psychiatry
Director, Anesthesiology Clinical Research Center
University of Rochester School of Medicine and Dentistry
Rochester, New York

John D. Markman, MD
Associate Professor
Director, Translational Pain Research Program
Department of Neurosurgery
University of Rochester School of Medicine and Dentistry
Rochester, New York

Click to Expand/Collapse Disclosures:

In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Robert H. Dworkin, PhD, has disclosed the following relevant financial relationships:
Researcher: Serono, US Food and Drug Administration, US National Institutes of Health
Consultant: Adynxx, Allergan, Analgesic Solutions, Avanir, Bayer, Biogen, Bristol-Myers Squibb, Cardiome, Depomed, EpiCept, Flexicon, Glenmark, Inhibitex, Johnson & Johnson, Lilly, MediciNova, MMS Holdings, NeurogesX, Ono Pharmaceutical, Pfizer, Phillips Respironics, RCT Logic, Sanofi-Aventis, Spinifex Pharmaceuticals, Theravance, US Department of Veteran Affairs

John D. Markman, MD, has disclosed the following relevant financial relationships:
Advisory Board: Nektar Therapeutics, Pfizer, Sanofi
Consultant: Forest Laboratories, NeurogesX

Dr. Markman discusses the unlabeled or investigational use of a commercial product.

Curatio CME Institute
Thomas Finnegan, PhD
, Associate Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.

Penn State College of Medicine
Penn State staff involved in the development and review of this activity, have disclosed no relevant financial relationships.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Penn State College of Medicine, and Purdue Pharma L.P. do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Penn State College of Medicine, or Purdue Pharma L.P. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

Privacy Policy
To view the myCME privacy policy, please click here.

To view the Penn State College of Medicine privacy policy, please click here.

Accredited Provider:

Co-sponsored by Penn State College of Medicine and Curatio CME Institute.

          

Commercial Supporter:

Support for this activity has been provided through an educational grant from Purdue Pharma L.P.

Instructions:

To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Participants should proceed with the activity until they have successfully completed this program, answered all pre-survey and post-test questions, completed the evaluation survey, and received a digital copy of the credit certificate. The online certificate will be saved on myCME.com within the participant’s Profile/Exam History, which can be accessed at any time.

If you have any questions relating to the accreditation or your certificate for this activity, please contact Penn State at ContinuingEd@hmc.psu.edu or or (717) 531-6483. Reference course #G5044-13-T.

If you have any other questions relating to this activity, please contact myCME.Support@haymarketmedical.com.

Click to Expand/Collapse SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.



Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

© 2013 Haymarket Media, Inc.

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education